Pharmaceutics · 2024 · 119 citations · 61 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryPharmaceutical FormulationCancer Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsAntibacterial PropertiesLipid VesiclesLipid-based Drug CarriersLipid-based Nanoparticle FormulationLiposomesNanocarriersNiosomal NanocarriersNiosome Drug Delivery
Niosomes are vesicular nanocarriers, biodegradable, relatively non-toxic, stable, and inexpensive, that provide an alternative for lipid-solid carriers (e.g., liposomes). Niosomes may resolve issues related to the instability, fast degradation, bioavailability, and insolubility of different drugs or natural compounds. Niosomes can be very efficient potential systems for the specific delivery of anticancer, antioxidant, anti-inflammatory, antimicrobial, and antibacterial molecules. This review aims to present an overview of their composition, the most common formulation techniques, as well as of recent utilizations as delivery systems in cancer therapy.
61
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
Colorectal cancer statistics, 2023
Rebecca L. Siegel, Nikita Sandeep Wagle, Andrea Cercek et al. · CA A Cancer Journal for Clinicians · 2023 · 3.8K citations · Full text
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh, Rogaie Rezaei-Sadabady, Soodabeh Davaran et al. · Nanoscale Research Letters · 2013 · 3.5K citations · Full text
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Melina Arnold, Eileen Morgan, Harriet Rumgay et al. · The Breast · 2022 · 3.2K citations · Full text